Hubei Shengmeikang Pharmaceutical Co.,Ltd., established in April 2017, is an enterprise introduced by the People's Government through investment promotion. The company is located in the "World Capital of Selenium" — Enshi Prefecture, Hubei Province. It is a production enterprise integrating cultivation of Chinese medicinal herbs, plant extraction, pharmaceutical intermediates, and bio-fermentation.Total investment reaches 200 million RMB. Current facilities include: Plant and Chinese medicinal material extraction workshops: approximately 8,500 square meters (including a Class D clean area of over 1,500 square meters);Bio-fermentation workshop: 1,700 square meters;Raw material and finished product warehouses: approximately 5,500 square meters;Technology Building: approximately 4,600 square meters.The company operates 3 plant and Chinese medicinal material extraction production lines, equipped with domestically leading multifunctional extraction equipment, enabling low energy consumption, intelligent, environmentally friendly, and high-efficiency extraction processes. The R&D and testing center supporting plant extraction, herbal processing, and bio fermentation production is equipped with instruments from top-tier European, American, and Japanese brands, such as Thermo Fisher high-performance liquid chromatographs (HPLC), gas chromatographs, and Shimadzu atomic absorption spectrophotometers.The wastewater treatment system uses advanced microbial treatment technology, ensuring water quality easily meets standards. The company has a complete R&D team and production/quality management personnel, all possessing high professional expertise.

The company's main products are plant-extracted pharmaceutical intermediates targeting domestic and international markets, including: Vitamin B2, Berberine Hydrochloride, Puerarin, Eucommia Ulmoides (Du Zhong) Extract, Magnolia Officinalis (Houpo) Extract, Epimedium (Yin Yang Huo) Extract, Rosemary Extract, Red Clover Extract, Cyclocarya Paliurus (Qing Qian Liu) Extract, Ampelopsis Grossedentata (Teng Cha) Extract, Patchouli Oil Extract, Glycyrrhiza Glabra (Licorice) Extract, Scutellaria baicalensis (Huang Qin) Extract, etc.

The company has passed the verification by Mengniu Group and is designated as the national exclusive producer of Cyclocarya Paliurus (Qing Qian Liu) Extract. It has also passed the GMP extension inspection by the Hubei Provincial Medical Products Administration. To date, registered/filed products include Scutellaria baicalensis (Huang Qin) Extract, Patchouli Oil Extract, and Glycyrrhiza Glabra (Licorice) Extract.

The company will consistently adhere to the development philosophy of heritage, pragmatism, and innovation, leveraging local resource advantages to extend its industrial chain from demonstration cultivation of raw materials, primary processing, deep processing, refined processing to R&D, registration, and production of finished formulations. Through academic and R&D collaborations with universities and research institutes, it will consolidate and enhance the quality and efficiency of traditional products while progressively advancing the **development and reserves of new products and technologies.Aiming to become a stable, reliable, and high-reputation supplier of pharmaceutical intermediates and plant extracts in the Wuling Mountain region and nationwide, the company is committed to achieving strong market competitiveness. It will also serve as a large-scale OEM manufacturer for domestic and international food, health products, and skincare enterprises.